Previous close | 58.00 |
Open | 57.72 |
Bid | 57.94 x 200 |
Ask | 58.74 x 200 |
Day's range | 56.10 - 58.67 |
52-week range | 42.21 - 76.98 |
Volume | |
Avg. volume | 509,788 |
Market cap | 2.918B |
Beta (5Y monthly) | 0.89 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Immunocore Holdings ( NASDAQ:IMCR ) Full Year 2023 Results Key Financial Results Revenue: US$249.4m (up 44% from FY...
Immunocore Holdings plc (NASDAQ:IMCR) Q4 2023 Earnings Call Transcript February 28, 2024 Immunocore Holdings plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the Immunocore Fourth Quarter Financial Results Conference Call. At this time, all participants are […]
Full Year and Q4 2023 Earnings Summary: KIMMTRAK Drives Revenue Surge as Clinical Pipeline Progresses